This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1997 Oct;40(4):468-74.

doi: 10.1093/jac/40.4.468.

Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients

M Denton¹, M H Wilcox

Affiliations

PMID: 9372414
DOI: 10.1093/jac/40.4.468

Review

Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients

M Denton et al. J Antimicrob Chemother. 1997 Oct.

. 1997 Oct;40(4):468-74.

doi: 10.1093/jac/40.4.468.

Authors

M Denton¹, M H Wilcox

Affiliation

¹ Department of Microbiology, University of Leeds, UK.

PMID: 9372414
DOI: 10.1093/jac/40.4.468

No abstract available

PubMed Disclaimer

Similar articles

Antimicrobial therapy against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia.
Geddes DM. Geddes DM. Chest. 1988 Aug;94(2 Suppl):140S-145S. doi: 10.1378/chest.94.2_supplement.140s. Chest. 1988. PMID: 3293940 Clinical Trial.
[Anti-Pseudomonas aeruginosa (Pa) antibiotic therapy and cystic fibrosis].
Bellon G, Gilly R. Bellon G, et al. Rev Mal Respir. 1991;8(2):263. Rev Mal Respir. 1991. PMID: 1907014 French. No abstract available.
Exacerbations in cystic fibrosis: 3--Management.
Smyth A, Elborn JS. Smyth A, et al. Thorax. 2008 Feb;63(2):180-4. doi: 10.1136/thx.2006.060905. Thorax. 2008. PMID: 18234661 Review.
Antibiotic therapy for chronic infection of pseudomonas in the lung.
Høiby N. Høiby N. Annu Rev Med. 1993;44:1-10. doi: 10.1146/annurev.me.44.020193.000245. Annu Rev Med. 1993. PMID: 8476233 Review.
Anti-pseudomonas activity of azlocillin during pulmonary infection in patients with cystic fibrosis.
Levy J, Baran D, Klastersky J. Levy J, et al. J Antimicrob Chemother. 1982 Sep;10(3):235-8. doi: 10.1093/jac/10.3.235. J Antimicrob Chemother. 1982. PMID: 6815156 Clinical Trial. No abstract available.

See all similar articles

Cited by

Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs.
Elborn JS, Prescott RJ, Stack BH, Goodchild MC, Bates J, Pantin C, Ali N, Shale DJ, Crane M. Elborn JS, et al. Thorax. 2000 May;55(5):355-8. doi: 10.1136/thorax.55.5.355. Thorax. 2000. PMID: 10770814 Free PMC article. Clinical Trial.
P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.
Sajjan US, Tran LT, Sole N, Rovaldi C, Akiyama A, Friden PM, Forstner JF, Rothstein DM. Sajjan US, et al. Antimicrob Agents Chemother. 2001 Dec;45(12):3437-44. doi: 10.1128/AAC.45.12.3437-3444.2001. Antimicrob Agents Chemother. 2001. PMID: 11709321 Free PMC article.
Epidemiological analysis of sequential Pseudomonas aeruginosa isolates from chronic bronchiectasis patients without cystic fibrosis.
Pujana I, Gallego L, Martín G, López F, Canduela J, Cisterna R. Pujana I, et al. J Clin Microbiol. 1999 Jun;37(6):2071-3. doi: 10.1128/JCM.37.6.2071-2073.1999. J Clin Microbiol. 1999. PMID: 10325384 Free PMC article.
Tobramycin administered by the TOBI(®) Podhaler(®) for persons with cystic fibrosis: a review.
Vandevanter DR, Geller DE. Vandevanter DR, et al. Med Devices (Auckl). 2011;4:179-88. doi: 10.2147/MDER.S16360. Epub 2011 Sep 20. Med Devices (Auckl). 2011. PMID: 22915944 Free PMC article.
Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Cheer SM, Waugh J, Noble S. Cheer SM, et al. Drugs. 2003;63(22):2501-20. doi: 10.2165/00003495-200363220-00015. Drugs. 2003. PMID: 14609360 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- Genetic Alliance
- MedlinePlus Health Information